OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold
Mohamed A. Abdelgawad, Alaa M. Hayallah, Syed Nasir Abbas Bukhari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1416-1416
Open Access | Times Cited: 18
Mohamed A. Abdelgawad, Alaa M. Hayallah, Syed Nasir Abbas Bukhari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1416-1416
Open Access | Times Cited: 18
Showing 18 citing articles:
Antineoplastic indole-containing compounds with potential VEGFR inhibitory properties
Dalia R. Aboshouk, Mohamed A. Youssef, Mohamed S. Bekheit, et al.
RSC Advances (2024) Vol. 14, Iss. 9, pp. 5690-5728
Open Access | Times Cited: 8
Dalia R. Aboshouk, Mohamed A. Youssef, Mohamed S. Bekheit, et al.
RSC Advances (2024) Vol. 14, Iss. 9, pp. 5690-5728
Open Access | Times Cited: 8
Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors
Mohammed Salah Ayoup, Ammar Ahmed, Hamida Abdel‐Hamid, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107102-107102
Closed Access | Times Cited: 6
Mohammed Salah Ayoup, Ammar Ahmed, Hamida Abdel‐Hamid, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107102-107102
Closed Access | Times Cited: 6
2‐Indolinone: An Anticancer Scaffold, Overview of the Studies and Approaches (2017–2024)
Taha Koulani, Asu Büşra Temizer, Nilgün Karalı
ChemistrySelect (2025) Vol. 10, Iss. 5
Closed Access
Taha Koulani, Asu Büşra Temizer, Nilgün Karalı
ChemistrySelect (2025) Vol. 10, Iss. 5
Closed Access
Twisted amides based on the spirohydantoin scaffold as potential anticancer agents
Anita Lazić, Relja Suručić, Nađa Grozdanić Stanisavljević, et al.
Journal of Molecular Structure (2025), pp. 141680-141680
Closed Access
Anita Lazić, Relja Suručić, Nađa Grozdanić Stanisavljević, et al.
Journal of Molecular Structure (2025), pp. 141680-141680
Closed Access
Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme
Shafeek Buhlak, Nadeem Abad, Jihane Akachar, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 233-233
Open Access
Shafeek Buhlak, Nadeem Abad, Jihane Akachar, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 233-233
Open Access
Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors
Manal M. Kandeel, Mohammed K. Abdelhameid, Mohamed A. Said, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1105-1105
Open Access
Manal M. Kandeel, Mohammed K. Abdelhameid, Mohamed A. Said, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1105-1105
Open Access
1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights
Tarfah Al‐Warhi, Hadia Almahli, Raed M. Maklad, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3203-3203
Open Access | Times Cited: 13
Tarfah Al‐Warhi, Hadia Almahli, Raed M. Maklad, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3203-3203
Open Access | Times Cited: 13
Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106735-106735
Closed Access | Times Cited: 10
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106735-106735
Closed Access | Times Cited: 10
Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
RSC Advances (2023) Vol. 13, Iss. 45, pp. 31908-31924
Open Access | Times Cited: 6
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
RSC Advances (2023) Vol. 13, Iss. 45, pp. 31908-31924
Open Access | Times Cited: 6
Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents
Prashant Chaudhari, Aditya Ramchandra Nemade, Atul A. Shirkhedkar
RSC Advances (2024) Vol. 14, Iss. 45, pp. 33384-33417
Open Access | Times Cited: 1
Prashant Chaudhari, Aditya Ramchandra Nemade, Atul A. Shirkhedkar
RSC Advances (2024) Vol. 14, Iss. 45, pp. 33384-33417
Open Access | Times Cited: 1
Synthesis and structural proof of novel oxazolo[5,4-d]pyrimidine derivatives as potential VEGFR2 inhibitors. In vitro study of their anticancer activity
Aleksandra Sochacka-Ćwikła, Andrzej Regiec, Żaneta Czyżnikowska, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107958-107958
Open Access | Times Cited: 1
Aleksandra Sochacka-Ćwikła, Andrzej Regiec, Żaneta Czyżnikowska, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107958-107958
Open Access | Times Cited: 1
Radiation-induced nanogel engineering based on pectin for pH-responsive rutin delivery for cancer treatment
Khaled El‐Adl, Mohamed Mohamady Ghobashy, Amel F.M. Ismail, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 1
Khaled El‐Adl, Mohamed Mohamady Ghobashy, Amel F.M. Ismail, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 1
Dual activity of indolin-2-ones containing an arylidene motif: DNA and BSA interaction
Syed Nasir Abbas Bukhari, Tariq G. Alsahli, Hasan Ejaz, et al.
RSC Advances (2023) Vol. 13, Iss. 40, pp. 28139-28147
Open Access | Times Cited: 3
Syed Nasir Abbas Bukhari, Tariq G. Alsahli, Hasan Ejaz, et al.
RSC Advances (2023) Vol. 13, Iss. 40, pp. 28139-28147
Open Access | Times Cited: 3
Novel Para-Aminobenzoic Acid Analogs and Their Potential Therapeutic Applications
Faisal Haroon, Umme Farwa, Maimoona Arif, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2686-2686
Open Access | Times Cited: 3
Faisal Haroon, Umme Farwa, Maimoona Arif, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2686-2686
Open Access | Times Cited: 3
Synthesis, characterization and molecular docking of benz-imidazolium Se-adducts: Antimicrobial and anticancer studies
Ahmad Hassan, Rizwan Ashraf, Muhammad Adnan Iqbal, et al.
Journal of Molecular Structure (2023) Vol. 1299, pp. 137160-137160
Closed Access | Times Cited: 3
Ahmad Hassan, Rizwan Ashraf, Muhammad Adnan Iqbal, et al.
Journal of Molecular Structure (2023) Vol. 1299, pp. 137160-137160
Closed Access | Times Cited: 3
Role of heterocycles in inhibition of VEGFR-2 – a recent update (2019–2022)
Atukuri Dorababu
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 416-432
Closed Access | Times Cited: 3
Atukuri Dorababu
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 416-432
Closed Access | Times Cited: 3
The anti‐breast cancer potential of indole/isatin hybrids
Ruo Wang, Renhong Huang, Yaofeng Yuan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 11
Closed Access | Times Cited: 2
Ruo Wang, Renhong Huang, Yaofeng Yuan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 11
Closed Access | Times Cited: 2
Computer‐Aided Design of VEGFR ‐2 Inhibitors as Anticancer Agents: A Review
Abdullahi İbrahim Uba
Journal of Molecular Recognition (2024)
Closed Access
Abdullahi İbrahim Uba
Journal of Molecular Recognition (2024)
Closed Access
